Key points are not available for this paper at this time.
These findings can help managers of CDTI programmes to ensure ivermectin reaches all segments of the population equally.
Brieger et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: